Norcantharidin is a synthetic anticancer compound which is a dual inhibitor for c-Met and EGFR in human colon cancers.

Regorafenib Hydrochloride is an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities.

Tyrphostin (AG 1296) is an inhibitor of PDGFR.

Motesanib Diphosphate is a potent ATP-competitive inhibitor of VEGFR1/2/3, similar activity against Kit, ~10-fold more selective for VEGFR than PDGFR and Ret.

SU-5614 is a potent and selective FLT3 inhibitor.

Canertinib Dihydrochloride is a pan-ErbB inhibitor.

Semaxanib (SU5416) is a potent and selective VEGFR (Flk-1/KDR) inhibitor.

Vatalanib (PTK787) 2HCl is an inhibitor of VEGFR2/KDR.